Drawray

Shenzhen Drawray Biotech Co., Ltd. was established in May 2019. The company is mainly engages in the R&D, production, sales and service of products in the field of diagnostics (IVD). Draway has five in-vitro diagnostic technology platforms including Mono-test CLIA, FIA, Microfluidics, Rapid Test and PCR. Its products cover cardiac markers, thyroid function, endocrine hormones, autoimmunity, respiratory viruses, reproductive health, bone metabolism, inflammation and infection, liver disease monitoring, allergen detection and other diagnosis fields. With continuous involvement in research and development every year, we have achieved over 90 CE and more than 40 patents.